Onchocerciasis News and Research

RSS
Onchocerciasis is a parasitic disease caused by the filarial worm Onchocerca volvulus. It is transmitted through the bites of infected blackflies of Simulium species, which carry immature larval forms of the parasite from human to human. In the human body, the larvae form nodules in the subcutaneous tissue, where they mature to adult worms. After mating, the female adult worm can release up to 1000 microfilariae a day. These move through the body, and when they die they cause a variety of conditions, including blindness, skin rashes, lesions, intense itching and skin depigmentation. Onchocerciasis is endemic in more than 25 nations located in a broad band across the central part of Africa. Small endemic foci are also present in the Arabian Peninsula (Yemen) and in the Americas (Brazil, Colombia, Ecuador, Guatemala, southern Mexico, and Venezuela).

Further Reading

HKI's Shawn Baker honored for groundbreaking research on malnutrition

HKI's Shawn Baker honored for groundbreaking research on malnutrition

OEPA reports substantial reduction of river blindness in six endemic countries

OEPA reports substantial reduction of river blindness in six endemic countries

Clinton Global Initiative to raise awareness and funding for NTD control and elimination

Clinton Global Initiative to raise awareness and funding for NTD control and elimination

Also in global health news: HIV/AIDS in Bangladesh; river blindness in Tanzania; potential immune system booster; compounds might fight TB

Also in global health news: HIV/AIDS in Bangladesh; river blindness in Tanzania; potential immune system booster; compounds might fight TB

1.4 million Nigerians over the age of 40 will become blind by 2020: Study

1.4 million Nigerians over the age of 40 will become blind by 2020: Study

Onchocerciasis elimination feasible with ivermectin treatment

Onchocerciasis elimination feasible with ivermectin treatment

Moxidectin being tested for onchocerciasis

Moxidectin being tested for onchocerciasis

BBC examines river blindness program in sub-Saharan Africa

BBC examines river blindness program in sub-Saharan Africa

Global Health Council names Jeffrey Sturchio as next leader

Global Health Council names Jeffrey Sturchio as next leader

Global health organizations are doing too little to support health system strengthening

Global health organizations are doing too little to support health system strengthening

River blindness under control in Escuintla, Guatemala

River blindness under control in Escuintla, Guatemala

Waging war on tropical diseases may be key to U.S. foreign policy

Waging war on tropical diseases may be key to U.S. foreign policy

More attention to neglected tropical diseases

More attention to neglected tropical diseases

Onchocerciasis parasite shows signs of resistance

Onchocerciasis parasite shows signs of resistance

Neglected tropical diseases, lymphatic filariasis, trachoma, leishmaniasis, onchocerciasis and schistosomiasis

Neglected tropical diseases, lymphatic filariasis, trachoma, leishmaniasis, onchocerciasis and schistosomiasis

Scientists solve genetic code of parasitic worm that causes elephantiasis

Scientists solve genetic code of parasitic worm that causes elephantiasis

Ivermectin is causing genetic selection in river blindness parasite

Ivermectin is causing genetic selection in river blindness parasite

WHO-based tropical disease research programme to focus on emerging diseases

WHO-based tropical disease research programme to focus on emerging diseases

Drug resistance of parasite which causes river blindness could lead to breakouts of the disease

Drug resistance of parasite which causes river blindness could lead to breakouts of the disease

WHO unveils new strategy to fight some of the most neglected tropical diseases

WHO unveils new strategy to fight some of the most neglected tropical diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.